IMNM · Company research
Immunome, Inc. (IMNM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| IMNM Initiated Coverage by William Blair -- Rating Set to Outperform - GuruFocus | IMNM Initiated Coverage by William Blair -- Rating Set to Outperform GuruFocus | View source ↗ | GuruFocus | Oct 16, 2026 | neutral | 0 | 0.6 |
| Immunome (IMNM) Stock Dropped, What Is Behind The Latest Attention? - Simply Wall Street | Immunome (IMNM) Stock Dropped, What Is Behind The Latest Attention? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 14, 2026 | neutral | 0 | 0.6 |
| Immunome, Inc. (IMNM) stock price, news, quote and history - Yahoo Finance UK | Immunome, Inc. (IMNM) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 14, 2026 | neutral | 0 | 0.6 |
| Immunome (IMNM) Following FDA Clearance Is Its Oncology Story Back In Value Focus - Yahoo Finance | Immunome (IMNM) Following FDA Clearance Is Its Oncology Story Back In Value Focus Yahoo Finance | View source ↗ | Yahoo Finance | Oct 13, 2026 | neutral | 0 | 0.6 |
| Immunome, Inc. (IMNM) stock price, news, quote and history - Yahoo Finance Australia | Immunome, Inc. (IMNM) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 3, 2026 | neutral | 0 | 0.6 |
| Immunome (IMNM) Stock May Be A Bargain After IM 1340 Clearance - Simply Wall Street | Immunome (IMNM) Stock May Be A Bargain After IM 1340 Clearance Simply Wall Street | View source ↗ | Simply Wall Street | Oct 1, 2026 | neutral | 0 | 0.6 |
| Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues - Yahoo Finance | Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues Yahoo Finance | View source ↗ | Yahoo Finance | Oct 1, 2026 | neutral | 0 | 0.6 |
| FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. - Stock Titan | FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Planned sale of 13,200 Immunome (NASDAQ: IMNM) shares disclosed in Rule 144 notice - Stock Titan | Planned sale of 13,200 Immunome (NASDAQ: IMNM) shares disclosed in Rule 144 notice Stock Titan | View source ↗ | Stock Titan | Sep 11, 2026 | neutral | 0 | 0.6 |
| Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon (IMNM) - Seeking Alpha | Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon (IMNM) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 13, 2026 | neutral | 0 | 0.6 |
| Insider Sale: Chief Medical Officer of $IMNM Sells 16,072 Shares - Quiver Quantitative | Insider Sale: Chief Medical Officer of $IMNM Sells 16,072 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 7, 2026 | neutral | 0 | 0.6 |
| Immunome lures 17 new hires with 344,000 stock options - Stock Titan | Immunome lures 17 new hires with 344,000 stock options Stock Titan | View source ↗ | Stock Titan | Jul 7, 2026 | neutral | 0 | 0.6 |
| Immunome: Varegacestat Is The Beachhead, But The ADC Engine Is The Thesis (NASDAQ:IMNM) - Seeking Alpha | Immunome: Varegacestat Is The Beachhead, But The ADC Engine Is The Thesis (NASDAQ:IMNM) Seeking Alpha | View source ↗ | Seeking Alpha | Jun 9, 2026 | neutral | 0 | 0.6 |
| IMNM - Immunome Inc Stock Price and Quote - Finviz | IMNM - Immunome Inc Stock Price and Quote Finviz | View source ↗ | Finviz | May 26, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $IMNM Buys 5,000 Shares - Quiver Quantitative | Insider Purchase: Director at $IMNM Buys 5,000 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | May 19, 2026 | neutral | 0 | 0.6 |
| Immunome Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire | Immunome Reports First Quarter 2026 Financial Results and Provides Business Update Business Wire | View source ↗ | Business Wire | May 12, 2026 | neutral | 0 | 0.6 |
| Immunome, Inc. Common Stock (IMNM) Stock Price: Oct 8 Close $19.31 - Gotrade | Immunome, Inc. Common Stock (IMNM) Stock Price: Oct 8 Close $19.31 Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.